Tolgabide
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141583This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0L55QF645F. European Medicines Agency schedules Tolgabide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11156MIG. Tolgabide generally arises in the molecular formula C18H18CL2N2O2. The term TOLGABIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) TOLGABIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tolgabide under HS 29252900 and SITC 51482. As of Q4 2014, TOLGABIDE remains the US FDA Preferred Term for this commodity. Tolgabide bears US NLM identifiers UMLS ID C2348800 and NCI Concept Code C72871. SMILES: CLC1=CC(=C(\NCCCC(=O)N)C2CCC(CL)CC2)\C(=O)C(=C1)C.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.